![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Apatinib Mesylate
2. Rivoceranib
3. Rivoceranib Mesylate
4. Yn-968d1
5. Yn968d1
1. 811803-05-1
2. Rivoceranib
3. Apatinib Free Base
4. Yn968d1
5. N-(4-(1-cyanocyclopentyl)phenyl)-2-((pyridin-4-ylmethyl)amino)nicotinamide
6. N-[4-(1-cyanocyclopentyl)phenyl]-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide
7. 5s371k6132
8. N-(4-(1-cyanocyclopentyl)phenyl)-2-(pyridin-4-ylmethylamino)nicotinamide
9. 3-pyridinecarboxamide, N-(4-(1-cyanocyclopentyl)phenyl)-2-((4-pyridinylmethyl)amino)-
10. Unii-5s371k6132
11. Apatinib (in China)
12. Rivoceranib [inn]
13. Rivoceranib (usan/inn)
14. Rivoceranib [usan]
15. Rivoceranib [who-dd]
16. Gtpl7648
17. Schembl1814966
18. Chembl3186534
19. Apatinib Free Base; Yn-968d1
20. Dtxsid601024366
21. Amy21302
22. Bcp02840
23. Ex-a1794
24. Hy-13342a
25. Mfcd21648511
26. Nsc772886
27. Nsc799333
28. S5248
29. Zinc70466461
30. Akos024464453
31. Ccg-268625
32. Db14765
33. Ds-7455
34. Nsc-772886
35. Nsc-799333
36. Sb16590
37. N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide
38. Ncgc00249393-01
39. Ncgc00249393-08
40. Ac-27461
41. Ba175030
42. Da-35324
43. Cs-0003200
44. C76598
45. D11288
46. Ab01274807-01
47. Ab01274807_02
48. Q27262801
49. N-[4-(1-cyanocyclopentyl)phenyl]-2-[(4-pyridinylmethyl)amino]nicotinamide
50. N-(4-(1-cyanocyclopentyl)phenyl)-2-((pyridin-4-ylmethyl)amino)pyridine-3-carboxamide
Molecular Weight | 397.5 g/mol |
---|---|
Molecular Formula | C24H23N5O |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 397.19026037 g/mol |
Monoisotopic Mass | 397.19026037 g/mol |
Topological Polar Surface Area | 90.7 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 608 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)